DAWES KAREN A

CIK 00012615065 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001261506

Recent Transactions

50 trades

Sale
REPLIGEN CORP$RGEN
Common Stock
2025-12-17$161.00/sh−275→ 91,821 total
Award
Barinthus Biotherapeutics plc.$BRNS
Share Option (Right to Buy)
2025-06-10+20,174→ 20,174 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2025-05-15+1,800→ 1,800 total
Award
REPLIGEN CORP$RGEN
Common Stock
2025-05-15+973→ 92,096 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2024-06-14$67.71/sh+2,953→ 88,170 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2024-06-14+2,953→ 0 total
Award
REPLIGEN CORP$RGEN
Common Stock
2024-05-16+803→ 88,170 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2024-05-16+1,576→ 1,576 total
Award
Barinthus Biotherapeutics plc.$BRNS
Share Option (Right to Buy)
2024-05-10+19,516→ 19,516 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2024-02-27$193.35/sh−1,000→ 87,367 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2024-02-27$42.07/sh+4,626→ 88,367 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2024-02-27+4,626→ 0 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2023-08-29+7,392→ 0 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2023-08-29$18.12/sh+7,392→ 84,591 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2023-08-29$171.38/sh−850→ 83,741 total
Award
REPLIGEN CORP$RGEN
Common Stock
2023-05-18+798→ 77,199 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2023-05-18+1,730→ 1,730 total
Award
Barinthus Biotherapeutics plc.$BRNS
Share Option (Right to Buy)
2023-05-11+19,197→ 19,197 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2022-09-09$227.17/sh−775→ 76,401 total
Award
Barinthus Biotherapeutics plc.$BRNS
Share Option (Right to Buy)
2022-06-15+18,604→ 18,604 total
Award
REPLIGEN CORP$RGEN
Common Stock
2022-05-26+644→ 77,176 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2022-05-26+1,565→ 1,565 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2022-05-25$149.18/sh−2,576→ 88,671 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2022-05-25$152.84/sh−742→ 76,532 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2022-05-25$151.14/sh−1,845→ 79,149 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2022-05-25$150.19/sh−7,677→ 80,994 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2022-05-25$152.14/sh−1,875→ 77,274 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2021-11-10+4,783→ 0 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-10$266.72/sh−486→ 91,865 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-10$267.75/sh−349→ 91,516 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-10$269.94/sh−255→ 91,261 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-10$271.28/sh−14→ 91,247 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-10$263.23/sh−1,119→ 93,175 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-10$262.28/sh−1,038→ 94,294 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-10$261.10/sh−236→ 95,332 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2021-11-10$26.12/sh−4,783→ 96,030 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-10$264.21/sh−336→ 92,839 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-10$259.75/sh−462→ 95,568 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-10$265.27/sh−488→ 92,351 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-02$306.49/sh−283→ 91,247 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-02$301.97/sh−446→ 92,886 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-02$304.23/sh−124→ 92,230 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-02$303.48/sh−532→ 92,354 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-02$305.91/sh−700→ 91,530 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-02$301.20/sh−251→ 93,332 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-02$299.02/sh−64→ 93,583 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-09-14$290.02/sh−13→ 93,908 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-09-14$294.06/sh−101→ 93,782 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-09-14$295.82/sh−27→ 93,647 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-09-14$295.02/sh−108→ 93,674 total

Companies

Recent Filings

Address

C/O REPLIGEN CORPORATION 41 SEYON STREET

WALTHAM, MA, 02453

View on SEC.gov